TGFBR2 and neoplasm: To ensure efficient knockout of Tgfbr2, the same TAM regimen (outlined in Fig. 1a) was first performed in DptIresCreERT2Rosa26LSLYFP reporter mice10 bearing subcutaneous KPR tumours.